Lactate infusion as therapeutical intervention: a scoping review.

Loes A van Gemert, Bastiaan E de Galan, Ron A Wevers, Rob Ter Heine, Michèl A Willemsen

Journal: European journal of pediatrics 2022;181(6):2227-2235

PMID: 35304646

Abstract

UNLABELLED

Traditionally, clinicians consider lactate as a waste product of anaerobic glycolysis. Interestingly, research has shown that lactate may serve as an alternative fuel for the brain to protect it against harm. The increasing scientific awareness of the potential beneficial side of lactate, however, is entering the clinic rather slowly. Following this, and realizing that the application of potential novel therapeutic strategies in pediatric populations often lags behind the development in adults, this review summarizes the key data on therapeutic use of intravenous infusion of sodium lactate in humans. PubMed and clinicaltrial.gov were searched up until November 2021 focusing on interventional studies in humans. Thirty-four articles were included in this review, with protocols of lactate infusion in adults with diabetes mellitus, traumatic brain injury, Alzheimer's disease, and cardiac disease. One study on lactate infusion in children was also included. Results of our literature search show that sodium lactate can be safely administrated, without major side effects. Additionally, the present literature clearly shows the potential benefits of therapeutic lactate infusion under certain pathological circumstances, including rather common clinical conditions like traumatic brain injury.

CONCLUSION

This review shows that lactate is a save, alternative energy source for the adult brain warranting studies on the potential therapeutic effects of sodium lactate infusion in children.

WHAT IS KNOWN

• Lactate is generally considered a waste product of anaerobic glycolysis. However, lactate also is an alternative fuel for different organs, including the brain. • Lactate infusion is not incorporated in standard care for any patient population.

WHAT IS NEW

• Thirty-four studies investigated the therapeutic use of intravenous sodium lactate in different patient populations, all with different study protocols. • Literature shows that lactate infusion may have beneficial effects in case of hypoglycemia, traumatic brain injury, and cardiac failure without the risk of major side effects.

© 2022. The Author(s).

Address: Department of Pediatric Neurology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands. [email protected].; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Internal Medicine, Maastricht UMC+, Maastricht, the Netherlands.; CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, the Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pediatric Neurology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.